Cargando…
Challenges in Commercializing Biomimetic Membranes
The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One categ...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704006/ https://www.ncbi.nlm.nih.gov/pubmed/26556379 http://dx.doi.org/10.3390/membranes5040685 |
_version_ | 1782408825131761664 |
---|---|
author | Perry, Mark Madsen, Steen Ulrik Jørgensen, Tine Braekevelt, Sylvie Lauritzen, Karsten Hélix-Nielsen, Claus |
author_facet | Perry, Mark Madsen, Steen Ulrik Jørgensen, Tine Braekevelt, Sylvie Lauritzen, Karsten Hélix-Nielsen, Claus |
author_sort | Perry, Mark |
collection | PubMed |
description | The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market—in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes. |
format | Online Article Text |
id | pubmed-4704006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-47040062016-01-21 Challenges in Commercializing Biomimetic Membranes Perry, Mark Madsen, Steen Ulrik Jørgensen, Tine Braekevelt, Sylvie Lauritzen, Karsten Hélix-Nielsen, Claus Membranes (Basel) Review The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market—in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes. MDPI 2015-11-05 /pmc/articles/PMC4704006/ /pubmed/26556379 http://dx.doi.org/10.3390/membranes5040685 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Perry, Mark Madsen, Steen Ulrik Jørgensen, Tine Braekevelt, Sylvie Lauritzen, Karsten Hélix-Nielsen, Claus Challenges in Commercializing Biomimetic Membranes |
title | Challenges in Commercializing Biomimetic Membranes |
title_full | Challenges in Commercializing Biomimetic Membranes |
title_fullStr | Challenges in Commercializing Biomimetic Membranes |
title_full_unstemmed | Challenges in Commercializing Biomimetic Membranes |
title_short | Challenges in Commercializing Biomimetic Membranes |
title_sort | challenges in commercializing biomimetic membranes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704006/ https://www.ncbi.nlm.nih.gov/pubmed/26556379 http://dx.doi.org/10.3390/membranes5040685 |
work_keys_str_mv | AT perrymark challengesincommercializingbiomimeticmembranes AT madsensteenulrik challengesincommercializingbiomimeticmembranes AT jørgensentine challengesincommercializingbiomimeticmembranes AT braekeveltsylvie challengesincommercializingbiomimeticmembranes AT lauritzenkarsten challengesincommercializingbiomimeticmembranes AT helixnielsenclaus challengesincommercializingbiomimeticmembranes |